Illumina turns down Roche's $5.7B bid

02/7/2012 | Reuters

Illumina's board rejected Roche's $5.7 billion takeover bid and advised shareholders not to tender their shares to Roche. Illumina said the bid undervalued the gene-sequencing firm. Roche called the offer "full and fair" and said it was ready to enter discussions with Illumina.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY